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Abstract
Chlamydophila (Cp.) psittaci, the causative agent of psittacosis in birds and humans, is the most important zoonotic
pathogen of the family Chlamydiaceae. These obligate intracellular bacteria are distinguished by a unique biphasic
developmental cycle, which includes proliferation in a membrane-bound compartment termed inclusion. All Chlamydiaceae
spp. possess a coding capacity for core components of a Type III secretion apparatus, which mediates specific delivery of
anti-host effector proteins either into the chlamydial inclusion membrane or into the cytoplasm of target eukaryotic cells.
Here we describe the interaction between Type III-secreted protein IncA of Cp. psittaci and host protein G3BP1 in a yeast
two-hybrid system. In GST-pull down and co-immunoprecipitation experiments both in vitro and in vivo interaction
between full-length IncA and G3BP1 were shown. Using fluorescence microscopy, the localization of G3BP1 near the
inclusion membrane of Cp. psittaci-infected Hep-2 cells was demonstrated. Notably, infection of Hep-2 cells with Cp. psittaci
and overexpression of IncA in HEK293 cells led to a decrease in c-Myc protein concentration. This effect could be ascribed to
the interaction between IncA and G3BP1 since overexpression of an IncA mutant construct disabled to interact with G3BP1
failed to reduce c-Myc concentration. We hypothesize that lowering the host cell c-Myc protein concentration may be part
of a strategy employed by Cp. psittaci to avoid apoptosis and scale down host cell proliferation.
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Introduction
The avian and human pathogen Cp. psittaci is the causative
agent of psittacosis and represents the most important animal
chlamydiosis of zoonotic character [1]. In addition, recent surveys
showed that Cp. psittaci can also be found in non-avian domestic
animals and wildlife [2,3]. All members of the family Chlamydiaceae
are obligate intracellular parasites that develop in a host cell within
an inclusion, i.e. a membrane-bound compartment that does not
fuse with lysosomes [4]. The membrane of the inclusion is initially
formed by invagination of the plasma membrane and pinching off
of a vesicle containing the infectious form of the bacterium, the
elementary body (EB). Thereafter, EBs differentiate into non-
infectious but metabolically active reticulate bodies (RB), which
proliferate within the expanding inclusion, giving rise to 1000 or
more progeny per host cell. The developmental cycle ends after 2–
3 days depending on the strain, when RBs transform back into EBs
and are released into the extracellular medium [5]. During this
unique biphasic developmental cycle replicating bacteria acquire
energy and biosynthetic precursors from the infected cell.
Furthermore, chlamydiae modulate cellular functions such as
apoptotic programs and immune response [6,7]. Studies on
inhibitors of bacterial protein synthesis suggest that modulation of
the host cell functions requires the activity of chlamydial proteins.
All Chlamydiaceae ssp. possess genes encoding core components of a
Type III Secretion (TTS) apparatus [8], a protein transport system
used by Gram-negative bacteria to translocate proteins into the
cytoplasm of the host cell. Therefore, it is commonly accepted that
chlamydial effector proteins are targeted by the TTS to the
inclusion membrane. The first set of chlamydial effector proteins
identified was a family of integral inclusion membrane (Inc)
proteins that share one remarkable feature, i.e. they possess a very
large (50–80 amino acids) bilobed hydrophobic domain, a
secondary structure motif predictive of protein localization to the
chlamydial inclusion membrane [9,10]. The first member of the
family of Inc proteins identified, IncA, is the one that has attracted
most of the attention. First cloned in Cp. caviae it has known
homologs in Chlamydia (C.) trachomatis, Cp. pneumoniae, Cp. felis, C.
muridarum, Cp. abortus and Cp. psittaci. The level of sequence
similarity among the homologs is low, and antibodies against IncA
do not cross-react with other chlamydial species. Furthermore, in
all IncA proteins identified so far, SNARE (soluble N-ethylmalei-
mide-sensitive factor attachment protein receptor) – like motifs
were identified [5]. These motifs allow interactions with several
host SNARE proteins, which are essential for membrane fusion
[11,12]. In addition to the bilobed hydrophobic domain Inc
proteins, such as IncA and IncG, harbor domains exposed to the
cytoplasmic side of chlamydial inclusion where they mediate
interactions with eukaryotic host proteins such as Rab GTPases
[13,14], 14-3-3b protein [15], and Act1 [16]. Thus, Inc proteins
are probably central regulators of pathogen-host interactions.
Ras-GTPase activating protein SH3 domain binding protein 1
(G3BP1) was initially identified as an ubiquitously expressed
cytosolic 68 kDa protein that co-immunoprecipitates with Ras-
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that G3BP1 is a 466-amino-acid protein that shares several
features with heterogeneous nuclear RNA-binding proteins,
including RNA recognition motifs (RRM) RNP1 and RNP2, an
RG-rich domain and acidic sequences [17]. G3BP1 colocalizes
and physically interacts with GAP at the plasma membrane of
serum-stimulated but not quiescent Chinese hamster lung
fibroblasts. In quiescent cells, G3BP1 was hyperphosphorylated
on serine residues and harbors a phosphorylation-dependent
RNase activity which specifically cleaves the 39-untranslated
region of human c-myc mRNA [18]. In addition of its role in
Ras-GAP signalling and its function as a phosphorylation-
dependent RNase several other putative biological activities of
G3BP1 were suggested, i.e. involvement in NFkB and IkB nucleo-
cytoplasmic equilibrium, interactions with ubiquitin-specific pro-
teases and participation in stress-granule formation (reviewed in
[19]). Moreover, the G3Bp family of proteins is evolutionarily
conserved throughout eukaryota [19].
In this study, we describe the interaction between the Type III-
secreted protein IncA of Cp. psittaci [20] and the host protein
G3BP1 in a yeast two-hybrid system. While there is a growing list
of publications dealing with interactions between Incs from C.
trachomatis and Cp. pneumoniae, this is, to our knowledge, the first
example of a documented interaction between an Inc protein from
a zoonotic chlamydia and a host protein. In GST-pull down and
co-immunoprecipitation experiments, both in vitro and in vivo
interaction between full-length IncA and G3BP1 could be shown.
Using fluorescence microscopy the localization of G3BP1 near the
inclusion membrane of Cp. psittaci-infected Hep-2 cells was
demonstrated. Finally, infection of Hep-2 cells with Cp. psittaci
and overexpression of IncA in HEK293 cells led to a decrease in c-
Myc protein concentration, but not at mRNA level. This effect
could be ascribed to the interaction between IncA and G3BP1
since overexpression of an IncA mutant construct disabled to
interact with G3BP1 did not cause a decrease in c-Myc
concentration. Additionally, siRNA mediated knock-down of
G3BP1 in Hep-2 cells had the same influence on c-Myc protein
level as overexpression of IncA.
Results
IncA of Cp. psittaci and the host protein G3BP1 interact in
a yeast two-hybrid system
To gain insights into pathogenicity mechanisms of zoonotic
Chlamydiaceae, we chose the cytoplasmic domain (aa 121-383) of the
inclusion membrane protein IncA from Cp. psittaci DC15 (Fig. 1A)
as a bait in a yeast two-hybrid screen for specific interactions with
target eukaryotic proteins. The localization of IncA from Cp.
psittaci in the inclusion membrane of infected cells was shown very
recently by fluorescence microscopy and immuno electron
microscopy [20]. Expression of the cytoplasmic domain of IncA
from Cp. psittaci fused to the GAL4 DNA-Binding domain (BD) in
pGBKT7 (CLONTECH) in Sacharomyces (S.) cerevisiae Y190
(CLONTECH) did not activate any of the reporter genes (HIS3,
lacZ) (Fig. 1B). Therefore this strain was mated with S. cerevisiae
Y187 expressing the HeLa cDNA MATCHMAKER 3 library in
the activation domain (AD) vector pGADT7-Rec (CLONTECH).
HeLa cDNA-expressing plasmids from clones growing on high
stringency medium were isolated and retransformed into compe-
tent yeast expressing BD-IncA (aa 121-383). In the case of positive
retransformation HeLa cDNA-expressing plasmids were recovered
from these strains, propagated in Echerichia (E.) coli and sequenced
to identify coding sequences. One isolate contained in frame
coding sequence for the C-terminal part (aa 221-451) of human
Figure 1. IncA of Cp. psittaci interacts with human G3BP1. (A)
Schematic structures of IncA of Cp. psittaci and human G3BP1.
Abbreviations: HD, hydrophobic domain; CD, cytoplasmic domain;
NTF2, Nuclear Transport Factor 2-like domain; AR, acid rich region; P,
proline rich motif; RRM, RNA recognition motif; RGG, arginine-glycine
rich box. (B) Specific interaction of the IncA-CD fused to GAL4 DNA-
binding domain (BD) with C-terminal part (aa 221-451) of G3BP1 fused
to GAL4 activation domain (AD) in yeast. Interactions were quantita-
tively assessed by b-galactosidase liquid culture activity assays. b-
galactosidase values represent the mean numbers and standard
deviations of three independent experiments.
doi:10.1371/journal.pone.0016692.g001
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cerevisiae Y190 expressing pGBKT7-IncA (aa 121-383) or only the
GAL4 BD were co-transformed with the G3BP1 HeLa-library
plasmid and the interaction was quantitatively assessed by b-
galactosidase (b-gal) activity assays (Fig. 1B). Compared with the
IncA-BD and pGADT7 (column 3) and pGBKT7 and AD-G3BP1
(aa 221-451) (column 2) vector controls, b-gal activity was
significantly induced in S. cerevisiae Y190 expressing pGBKT7-
IncA (aa 121-383) and AD-G3BP1 (aa 221-451) (column 1). The
G3BP1 HeLa-library fragment encludes the characteristic RNA
recognition motifs of G3BP1 (Fig. 1A). To further narrow down
the interaction surface between IncA and G3BP1 we deleted the
RRM resulting in an AD-G3BP1 (aa 377-451) construct (Fig. 1B).
As shown in Figure 1B, column 4, deletion of the RRM led to the
complete loss of interaction with IncA (aa 121-383) in the yeast
two-hybrid system. Taken together, these data indicate that the
cytoplasmic domain of Cp. psittaci IncA specifically interacts with
the C-terminal part of human G3BP1 in the yeast two-hybrid
system.
Full-length proteins IncA of Cp. psittaci and human
G3BP1 interact in vitro and in vivo in HEK293 cells
Next we performed GST pull-down assays to examine whether
IncA and G3BP1 directly interact in vitro. Glutathione Sepharose
beads bound to GST-tagged full-length IncA, GST-IncA (aa 121-
383) or GST alone (Fig. 2A) were incubated with [
35S]methionine-
labeled full-length G3BP1, processed as described in Materials and
Methods section and analyzed by autoradiography. As shown in
Figure 2B, full-length G3BP1 bound specifically to both the GST-
IncA (aa 121-383) and the GST-IncA full-length matrix, but no
binding was detected using GST as a control, suggesting a direct
physical interaction between IncA of Cp. psittaci and human
G3BP1. In the reversed experiment IncA (aa 121-383) bound
specifically to the GST-G3BP1 (aa 1-466) matrix (Fig. 2C and D).
In a second approach, we performed a GST pull-down
experiment with Hep-2 cell lysates instead of [
35S]methionine-
labeled full-length G3BP1. The associated proteins were pelleted
by centrifugation, washed and analyzed for full-length G3BP1 by
Western blot analysis (Fig. 2E). Endogenous G3BP1 from Hep-2
cell lysate exclusively bound to GST-IncA (aa 121-383) and GST-
IncA and did not interact with GST alone. Finally, in order to
show that IncA and G3BP1 also interact in vivo, HEK293 cells
were transfected with a His-tagged IncA mammalian expression
construct. To get a stronger expression of the heterologous protein
the codon usage of the IncA gene of Cp. psittaci was adapted to
human cells. As shown in Figure 2E we were able to co-
immunoprecipitate endogenous G3BP1 with His-tagged IncA
using an anti-His antibody. No binding was obtained using pre-
immune serum or Protein G-Sepharose beads only as negative
controls. Consequently, our interaction studies showed that IncA
and G3BP1 interact in vitro and in vivo. The cytoplasmic domain of
IncA was proved sufficient to bind the full-length G3BP1.
G3BP1 is accumulated around the chlamydial inclusion in
Cp. psittaci-infected Hep-2 cells
As IncA of Cp. psittaci is localized on the membrane of the
chlamydial inclusion [20], interaction with G3BP1 should lead to
accumulation of G3BP1 in the vicinity of the inclusion. To test this
assumption, we performed immunolocalization studies of endog-
enous G3BP1 in Cp. psittaci-infected and non-infected Hep-2 cells
using polyclonal rabbit anti-G3BP1 antibody (Fig. 3). In non-
infected Hep-2 cells, G3BP1 showed a uniformly cytoplasmic
localization (Fig. 3, 1–3). In Cp. psittaci-infected Hep-2 cells, a
fraction of G3BP1 was found to be concentrated around the
chlamydial inclusion as shown in Fig. 3 (4–6, inclusion in red). An
alternative approach, the transfection of infected Hep-2 cells with
a DsRed-G3BP1 expression vector, gave disappointing results
because overexpression of G3BP1 induced assembly of stress
granules [21,22] which prevented any further study (data not
shown). In summary, the immunolocalization data show an
accumulation of G3BP1 around chlamydial inclusions which is
due if IncA and G3BP1 interact.
Infection of Hep-2 cells with Cp. psittaci leads to a
decrease in c-Myc protein concentration, but does not
affect c-myc mRNA concentration
As it is known that G3BP1 harbors a phosphorylation-
dependent RNase activity which specifically cleaves the 39-
untranslated region of human c-myc mRNA [18], we wondered
whether changes in c-myc mRNA and/or protein concentration
would be detectable in Cp. psittaci-infected Hep-2 cells. For this
purpose, Hep-2 cells were infected with Cp. psittaci at a MOI of 3,
with heat-inactivated Cp. psittaci, or chloramphenicol-treated after
infection as controls. Total RNA was isolated at different time
points of infection and reverse transcribed into cDNA. Expression
levels of c-myc mRNA and. b-actin as a control were estimated by
semi-quantitative PCR (Fig. 4A, above) and by quantitative Real-
Time PCR using GAPDH for standardization (Fig. 4A, below). In
both experiments no differences in c-myc mRNA levels during the
course of infection were detectable in comparison with the control
(Fig. 4A). But to our surprise, the c-Myc protein concentration
significantly declined in Cp. psittaci infected cells with progressive
infection under the same experimental conditions (Fig. 4B, middle
column). No changes in c-Myc protein concentration were
detected in Hep-2 cells treated with heat-inactivated Cp. psittaci
(Fig. 4B, left column). This inhibitory effect required bacterial
protein synthesis as the level of c-Myc protein was nearly
unchanged in Cp. psittaci-infected cells treated with chloramphen-
icol (Fig. 4B, right column). Protein levels of c-Myc were
standardized to b-actin (Fig. 4B, below).These findings suggest
that infection of Hep-2 cells with Cp. psittaci leads to a decrease in
the c-Myc protein concentration of the host cell.
The decrease in c-Myc concentration could be ascribed
to the interaction between IncA and G3BP1
To find out whether the decrease in c-Myc protein concentra-
tion during Cp. psittaci infection of mammalian cells is somehow
connected with chlamydial IncA, we transfected HEK293 cells
with a mammalian expression vector containing the HA-tagged
codon-adapted cytoplasmic domain of IncA (aa 121-383) from Cp.
psittaci, or the vector only as a control. Overexpression of this IncA
fragment in HEK293 cells led to a decrease of c-Myc protein
concentration in the same manner as in Cp. psittaci-infection of
Hep-2 cells (Fig. 5C, lanes 1 and 2). This prompted us to
hypothesize that the decrease in c-Myc protein concentration was
caused by the recruitment of G3BP1 to the cytoplasmic portion of
Cp. psittaci IncA. To verify this hypothesis we generated a mutant
of IncA (aa 121-383) that was no longer able to interact with
G3BP1. Mutagenesis as performed in S. cerevisiae using error-prone
PCR (see Materials and Methods section) resulted in an IncA (aa
121-383) double mutant (N159S; S237G), which failed to interact
with G3BP1 in the yeast two-hybrid system (Fig. 5A and B,
column 3). The following overexpression of this mutant in
HEK293 cells had no effect on c-Myc protein concentration
(Fig. 5C, column 3). Assuming that recruitment of G3BP1 to IncA
on the surface of inclusion is responsible for decrease in c-Myc
IncA of Cp. psittaci Interacts with Human G3BP1
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should have a similar effect. We therefore treated Hep-2 cells with
a pool of four siRNAs specific for G3BP1 and as a control with
non-targeting siRNAs and analyzed the G3BP1 and c-Myc protein
concentrations by Western blot (Fig. 5D). As expected, downreg-
ulation of G3BP1 at approximately 50% led to a corresponding
downregulation of c-Myc whereas the treatment of cells with
control siRNA had no effect (Fig. 5D). As in the case of infection of
Hep-2 cells by Cp. psittaci the c-myc mRNA level remained
unchanged. We therefore conclude that the decrease in c-Myc
protein concentration resulting from IncA (aa 121-383) in
HEK293 cells and most likely also from infection of Hep-2 cells
with Cp. psittaci can be ascribed to the interaction between IncA
and G3BP1.
Discussion
All Chlamydiaceae express a TTS apparatus [8] capable of
mediating specific delivery of anti-host effector proteins either into
the chlamydial inclusion membrane or into the cytoplasm of target
Figure 2. Full-length IncA of Cp. psittaci and G3BP1 proteins interact in vitro and in vivo. (A) Purified GST, GST-IncA (aa 1-338) and GST-IncA
(aa 121-383) or (C) GST and GST-G3BP1 (aa1-466) stained with Coomassie. (B) Results of GST pull-down experiments performed with IncA full-length
and truncation clone fused to GST and [
35S]-methionine-labeled full-length G3BP1 or (E) with Hep-2 cell lysate instead of labeled G3BP1. (D) Results of
GST pull-down experiment performed with full-length G3BP1 fused to GST and [
35S]-methionine-labeled IncA (aa 121-383). GST served as control. IVT:
10 ml of the in vitro translation product. Input: 25% (75 mg protein) of Hep-2 cell lysate used for the interaction assay. (F) Whole cell lysate of HEK293
cells transfected with a His-tagged codon-adapted IncA mammalian expression construct was subjected to co-immunoprecipitation experiments
using anti-His antibody. Co-immunoprecipitated endogenous G3BP1 was detected with a mouse anti-G3BP1 monoclonal antibody. Controls were
beads alone (c) or pre-immune serum (lgG). Input: 10% (100 mg) of the protein used for immunoprecipitation.
doi:10.1371/journal.pone.0016692.g002
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anti-host effector proteins are the Inc proteins. IncA was the first
member of the Inc protein family to be identified, and it is still the
only member of the Inc family for which a function has been
proposed,namely involvement in the homotypic fusion of inclusions
in C. trachomatis. In this process, the already mentioned SNARE-like
motif within the cytoplasmic domain of IncA may play a role [5].
Despite the low sequence similarity among IncA proteins of the
various Chlamydiaceae spp., conservation of biochemical properties of
IncA proteins from Cp. caviae and C. trachomatis was found [5]. Both
proteins self-associate to form multimers. When artificially ex-
pressed bythe host cell, they localize to the endoplasmatic reticulum
and completely inhibit concomitant inclusion development when
additionally infected with Cp. caviae or C. trachomatis.
While the present knowledge on IncA functionality almost
entirely refers to the human pathogens C. trachomatis and Cp.
pneumoniae, we focused on the IncA protein of the zoonotic agent Cp.
psittaci using a yeast two-hybrid screen to search for interacting host
proteins that could indicate further functions of this protein. Having
identified human G3BP1 as an interaction partner of IncA of Cp.
psittaci in yeast, we conducted GST pull-down and co-immunopre-
cipitation experiments that confirmed the interaction between both
proteins in vitro as well as in vivo in HEK293 cells transfected with an
IncA-expression construct. Moreover, an accumulation of G3BP1
around the chlamydial inclusion was shown in Cp. psittaci-infected
Hep-2 cells by means of fluorescence microscopy.
Consequently, the question of functional relevance of the IncA-
G3BP1 interaction arose. As shown by Gallouzi et al., G3BP1 is
hyperphosphorylated on serine residues and harbors a phosphor-
ylation-dependent RNase activity that specifically cleaves the 39-
untranslated region of human c-myc mRNA [18]. Rather unexpect-
edly, our finding that c-myc mRNA concentrations were practically
unchanged in the course of Cp. psittaci infection of Hep-2 cells was in
contrast to the significant decrease in c-Myc protein. Overexpres-
sion of IncA in HEK293 cells caused the same effect, whereas an
IncA mutant disabled to interact with G3BP1 in yeast did not cause
a decrease in c-Myc protein concentration. Moreover, siRNA-
mediated knockdown of G3BP1 in Hep-2 cells also downregulated
c-Myc. This suggests that the effect could be ascribed to the
interaction between IncA and G3BP1. Absence of the possibility to
modify Chlamydia experimentally precluded us from proving this
hypothesis in more detail. We have currently no definitive
explanation for a connection between IncA-G3BP1 interaction
and c-Myc concentration. An intriguing possibility is that
interaction between these proteins disrupts a still unknown c-Myc-
stabilizing interaction of G3BP1 with other host proteins thereby
rendering c-Myc susceptible to degrading activity. An example for
such a protein-stabilizing interaction of G3BP1 is the complex with
USP10, a ubiquitin-specific protease, described for human [23] and
yeast cells [24]. USP10 removes ubiquitin from proteins to which it
is attached, leading to stabilization of the protein. At least for S.
cerevisiae it was shown that USP10 requires an additional protein, i.e.
G3BP1, to form an active de-ubiquitination complex that cleaves
ubiquitin from specific substrates [24]. Whether the USP10 –
G3BP1 complex is relevant for the stabilization of c-Myc protein in
human cells remains to be elucidated.
The c-Myc transcription factor is a powerful regulator of cell
growth, proliferation, differentiation and apoptosis [25,26]. Given
its potent effects on cell fate, it is not surprising that cells have
employed sophisticated methods for ensuring proper c-Myc
expression levels. The expression of c-Myc is regulated at every
possible level: transcriptionally (initiation and elongation), post-
transcriptionally (mRNA stability and translation) and post-
translationally (protein stability) [27]. In 1994, the Eick and Hay
laboratories provided evidence that c-Myc deregulation activates
the tumor suppressor p53 and triggers apoptosis, a process, highly
relevant for chlamydial development [28,29]. Zindy and colleagues
in the Roussel laboratory showed mechanistically that deregulated
Figure 3. G3BP1 is accumulated around the chlamydial inclusion in Cp. psittaci infected Hep-2 cells. Hep-2 cells were infected with Cp.
psittaci at a MOI of 3, and at 48 h postinfection the cells were fixed and stained with anti-chlamydial LPS (red), anti-G3BP1 (green) antibodies and
DAPI (blue, nuclei), and viewed under a fluorescence (1–3) or a confocal laser-scanning microscope (4–6). Non-infected cells served as control (1–3).
The anti-G3BP1 (1 and 4) and anti-LPS (5) or DAPI (2) signals were merged (3 and 6). A fraction of endogenous G3BP1 is concentrated around
chlamydial inclusions (6). Bar=20 mm.
doi:10.1371/journal.pone.0016692.g003
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cohort of target genes involved in apoptosis [30]. Afterwards several
other c-Myc-induced pathways that contribute to the apoptotic
response were described [31]. Obligate intracellular Chlamydiaceae
depend on an intact host cell for replication and production of
infective progeny. Therefore, they possess diverse strategies to
prevent apoptotic cell death in the host [32]. One of these is the
proteasomal degradation of pro-apoptotic BH3-only proteins by the
chlamydial protease/proteasome-like activity factor (CPAF) [33].
Another successful mechanism is the upregulation of anti-apoptotic
Bcl-2 like proteins such as Mcl-1 [34]. We suggest here another
possible strategy employed by Cp. psittaci to overcome host cell
apoptotic mechanisms, i.e. the inhibition of c-Myc-driven apoptotic
events by lowering c-Myc protein concentration.
In addition to apoptosis regulation, another aspect of c-Myc
effects on cell fate is highly relevant to chlamydial development, i.e.
the regulation of cell cycle and, therefore, proliferation. c-Myc
enables cell growth by providing the cell with an abundant supply of
several classes of basic building blocks, as well as increasing cell
metabolism and protein synthesis. Several c-Myc target genes are
thought to have a role in this activity, including those associated
with cellular metabolism, ribosomal and mitochondrial biogenesis,
as well as protein and nucleic acid synthesis [27]. Furthermore,
expression profiling data indicate that c-Myc has the capacity to
both stimulate cell growth and abrogate cell cycle inhibitors, a
powerful combination of functions that, when deregulated, may
drive the limitless replicative potential characteristic of nearly all
tumors [26]. Regarding Chlamydiaceae, it is widely accepted that they
develop predominantely within terminally differentiated epithelial
cells of mammalian mucosae and not within actively dividing cells
[35]. Furthermore, studies on C. trachomatis showed that host cells
infected with C. trachomatis undergo a lower rate of cell division than
Figure 4. Infection of Hep-2 cells with Cp. psittaci leads to a decrease in c-Myc protein concentration. Hep-2 cells were infected with Cp.
psittaci at a MOI of 3, with heat-inactivated Cp. psittaci or chloramphenicol-treated after infection as controls, and at different hours postinfection
(hpi) cells were lysed for RNA or protein analysis. (A, above) Semi-quantitative (sq) PCR shows the unchanged expression of c-myc mRNA in infected
(middle column), infected and chloramphenicol-treated (right) and control (left) Hep-2 cells. b-actin served as an internal control gene. (A, below)
Quantitative Real-Time (qRT) PCR. c-myc levels were standardized on GAPDH. Experiments were performed three times in duplicate. (B) Immunoblots
of whole cell lysates of Cp. psittaci infected (middle column), infected and chloramphenicol-treated (right) and control (left) cells probed with anti-
LPS, anti-c-Myc and anti-b-actin antibodies. Bar diagrams below the immunoblots represent a quantification of c-Myc protein related to b-actin
protein concentration. Experiments were performed three times.
doi:10.1371/journal.pone.0016692.g004
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inhibitshostcell cytogenesis[37]and inducescleavage ofthemitotic
cyclin B1 [38]. We propose that the downregulation of c-Myc
protein concentrationduringinfection of Hep-2cells withCp. psittaci
is an alternative way to reduce host cell proliferation and so to
establish optimal conditions for development of this obligate
intracellular microorganism within the host cell.
Materials and Methods
Cell culture and organisms
Hep-2 cells (ATCC-CCL23) were grown in DMEM medium
with 4.5 g/l glucose (PAA) supplemented with 10% heat-
inactivated fetal calf serum (FCS) and maintained at 37uCi na n
atmosphere of 5% CO2. Sub-confluent monolayers were inocu-
Figure 5. The decrease in c-Myc protein concentration can be ascribed to the interaction between IncA and G3BP1. (A) Schematic
structure of the Cp. psittaci IncA (aa 121-383) double mutant (N159S; S237G) which is no longer able to interact with G3BP1 in the yeast two-hybrid
system. Mutagenesis was performed in S. cerevisiae using error-prone PCR. (B) Yeast two-hybrid interaction assay of mutated IncA with G3BP1.
Interactions were quantitatively assessed by b-galactosidase liquid culture activity assays. b-galactosidase values represent the mean numbers and
standard deviations of three independent experiments. (1) GAL4 BD-IncA (aa 121-383)-EGFP + pGADT7 (negative control), (2) GAL4 BD-IncA (aa 121-
383)-EGFP + GAL4 AD-G3BP1 (aa 221-451) (positive control), (3) GAL4 BD-IncA (aa 121-383, N159S; S237G)-EGFP + GAL4 AD-G3BP1 (aa 221-451). (C)
Immunoblots of whole HEK293 cell lysates transfected with pcDNA3 (1), pcDNA3-HA-IncA (aa 121-383) (2) or pcDNA3-HA-IncA (aa 121-383, N159S;
S237G) (3) and probed with anti-HA, anti-c-Myc and anti-b-actin antibodies. Bar diagram below the immunoblots represent a quantification of c-Myc
protein concentration related to b-actin. Experiments were performed in triplicate. (D) Immunoblots of whole Hep-2 cells untreated (1), transfected
with non-targeting siRNA (2) or transfected with ON-TARGET G3BP1 siRNA pool and probed with anti-G3BP1, anti-c-Myc and anti-b-actin antibodies.
Bar diagrams show knock-down rate of G3BP1 and c-Myc standardized to b-actin and the c-myc mRNA concentrations estimated by qRT-PCR.
Experiments were performed in triplicate.
doi:10.1371/journal.pone.0016692.g005
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heat-inactivated DC15 at a multiplicity of infection (MOI) of 3.
After centrifugation at 2.000 rpm and 37uC for one hour they
were maintained as described above. For inhibition of chlamydial
protein synthesis cells were treated with 200 mg/ml chloramphen-
icol. HEK293 cells (ATCC-CRL1573) were cultivated in RPMI
medium with L-glutamine (PAA) supplemented with 10% heat-
inactivated FCS under mentioned conditions.
Mammalian expression constructs and transfections
To obtain an optimal expression of IncA in human cells full-
length DNA sequence of IncA of Cp. psittaci was optimized for
human codon usage (sequence available on demand), in vitro
synthesized (GenScript) and cloned asan EcoRI-NotI-fragment into
pcDNA3.1/myc-His A (Invitrogen). To express HA-tagged codon
adaptedcytoplasmicdomainofIncA(aa121-383)fromCp.psittaciin
mammalian cells the corresponding DNA fragment was amplified
by PCR using the following primers: forward-59- GCGAATT-
CACCATGTACCCATACGATGTTCCAGATTACGCTACC-
CCCAGCCAGGTGGCCCGG-39, reverse-59-CGCCTCGAGT-
TACTGCTCGTAGATGGGGAAGCCCT-39 and the full-length
pcDNA3.1/myc-His A-construct (see above) or the mutated
construct (see below) as template. EcoRI-XhoI-digested PCR
fragments were transferred into pcDNA3 (Invitrogen). HEK293
cells were transfected with FuGENEH HD transfection reagent
according to the manufacturer’s instructions (Roche) and incubated
for 24 hours.
For siRNA experiments Hep-2 cells were transfected with ON-
TARGET plus Non-Targeting siRNA #1 or ON-TARGET plus
SMART pool human G3BP1 using DharmaFECT 1 transfection
reagent as described by the manufacturer (Thermo Scientific
DharmaconH), maintained for 72 hours and lysed as mentioned
below.
Co-immunoprecipitation
HEK293 cells were transfected with pcDNA3.1/myc-His full-
length codon-adapted IncA expression construct and maintained
for 24 hours. Co-immunoprecipitation was performed with
mMACS Protein G microbeads as described by the manufacturer
(Miltenyi Biotec). Transfected HEK293 cells were washed twice
with cold PBS, harvested and resuspended in low-salt lysis buffer.
Cell lysate was incubated with monoclonal mouse anti-His
antibody (Roche) and mMACS Protein G microbeads on ice.
After 45 minutes magnetic separation using microcolumns and the
mMACS separator was performed. Samples were extensively
washed and co-immunoprecipitated proteins were eluted from the
column with SDS gel loading buffer.
Immunoblotting
For immunoblotting of co-immunoprecipitated proteins, sam-
ples were loaded on a 10% SDS-PAGE and transferred to a
nitrocellulose membrane (Whatman). Membranes were blocked
with 5% skim milk in TBST for 1 h and incubated overnight at
4uC with mouse anti-His (Roche) or mouse anti-G3BP1 (Santa
Cruz Biotechnology) primary antibodies. After washing three
times with TBST membranes were incubated with horseradish
peroxidase-conjugated goat anti-mouse secondary antibody (Dia-
nova). For detection of protein bands ECL Plus Western Blotting
Detection Reagent (GE Healthcare) was used as recommended.
For Western blot analyses of infection experiments, Hep-2 cells
were collected at different time points, washed twice with cold PBS
and lysed using RIPA-buffer (150 mM NaCl, 65 mM Tris-HCl
pH 7.5, 1% sodium deoxycholate, 1% Triton-X 100, 0.1% SDS).
For detection of protein bands mouse anti-c-Myc (Santa Cruz
Biotechnology), mouse anti-b-actin (Sigma Aldrich) and mouse
anti-chlamydial LPS (AbD Serotec) primary antibodies and goat
anti-mouse secondary antibody (Dianova) were used. Hep-2 cells
treated with siRNA and HEK293 cells transfected with HA-tagged
IncA expression vectors were treated equally. Detection occurred
with monoclonal mouse anti-HA, mouse anti-G3BP1 and mouse
anti-c-Myc (all obtained from Santa Cruz Biotechnology) primary
antibodies and secondary anti-mouse antibody (Dianova).
Immunofluorescence and confocal microscopy
Hep-2 cells grown on coverslips were transfected with DsRED-
G3BP1 expression construct (obtained from Zhi-Min Yuan,
Harvard School of Public Health, Boston, USA) or DsRed vector.
After 24 hours cells were infected with Cp. psittaci DC15 at a MOI
of 3 and incubated for additional 48 hours. Infected and
uninfected Hep-2 cells were washed with PBS and fixed with
3,8% paraformaldehyde. For neutralization cells were washed
twice with 0,1 M glycin/PBS followed by permeabilization in
0,5% NP-40/PBS for 10 min. Then cells were blocked with PBS
containing 0,1% NP-40 and 5% FCS overnight at 4uC.
Immunostaining of endogenous G3BP1 occurred with polyclonal
rabbit anti-G3BP1 antibody (Abcam), inclusions were visualized
using mouse anti-chlamydial LPS antibody (AbD Serotec) by
incubation for 1, 5 h at room temperature. After washing four
times with 0,1% NP-40/PBS secondary FITC-conjugated goat
anti-rabbit (Dianova) and RRX-conjugated goat anti-mouse
(Dianova) were incubated for 1 h. All samples were additionally
stained with 0,1 mg/ml DAPI, extensively washed with 0,1% NP-
40/PBS, PBS and A. bidest. and mounted with MountFluor (Pro
Taqs). Images of infected and immunostained Hep-2 cells were
collected with a BX51 fluorescence microscope (Olympus) or an
Axiovert 200 M/LSM 510 META laser scanning confocal
microscope (Carl Zeiss, Jena) according to [40].
RNA isolation, semi-quantitative PCR and qRT-PCR
Hep-2 cells were infected as described above and collected at
different time points. For RNA purification RNeasy Mini Kit and
QIAshredder (Qiagen) were used according to manufacturer’s
instructions. For DNA digestion samples were treated with RQ1
RNase-free DNase (Promega) and purified with RNA Clean and
Concentrator (Zymo Research) according to usage informations.
Reverse transcription was done using M-MLV Reverse Transcrip-
tase RNase H Minus (Promega), 0, 5 mg RNA, 1 mg oligo(dT)12-18
(Roth), 10 mM of each dNTP, 5 mlo f5 6reaction buffer, 40 U of
RiboLock
TM RNase inhibitor (Fermentas) and 100 U M-MLV RT
(H-) in a total volume of 25 ml according to manufacturer’s
instructions. With all RNA samples control reactions without
reverse transcriptase during production of the cDNA which was
subsequently used in the PCR were performed. For semi-
quantitative PCR with 1 U Pwo-DNA-Polymerase (Peqlab), 1 ml
of cDNA sample, 10 mM of each dNTP, 5 mlo f1 0 6Pwo-reaction
buffer and 10 mM of according primers were used in a total volume
of 50 ml. Primer set: c-myc for: 59-GCCAGAGGAGGAAC-
GAGCT-39 and c-myc rev: 59-GGGCCTTTTCATTGTTTTCC-
A-39; b-actin for: 59-CTGGAACGGTGAAGGTGACA-39 and b-
actin rev: 59-AAGGGACTTCCTGTAACAATGCA-39. The fol-
lowing temperature-time profile was used: initial denaturation at
95uC for 5 min, 25 cycles of 95uC for 1 min, 55uC for 45 sec and
72uC for 45 sec, and a final elongation step at 72uC for 2 min. PCR
products were electrophoresed on an 1% agarose gel containing
ethidium bromide and visualized on an UV transilluminator.
For quantitative Real-Time PCR cDNA samples were diluted
1:10 inRNase-free water.2 ml ofeachsample, 0,2 mMof primers,c-
myc for and c-myc rev (see above) or GAPDH for: 59-TGCACCAC-
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TGGTCATGAG-39, and SsoFast
TM EvaGreenH supermix with
Low ROX (BIO-RAD) in a total volume of 20 ml were used. PCR
was performed in StepONE Real-Time PCR-system: 95uC for
2 min, 40 cycles of 95uC for 5 sec and 62uC for 20 sec, and
analyzed with StepONE software v2.0 (Applied Biosystems).
Yeast two-hybrid assay
The full-length IncA of Cp. psittaci DC15 was PCR amplified using
chromosomal DNA of this species as template and the following
primer sets: IncAPsi1: 59-GCGAATTCATGACATCACCAGTA-
GAATCT-39 and IncAPsi2: 59-GCGGATCCTTACTGTTCATA-
TATTGGGAA-39 (aa 1-383). The cytoplasmic domain of IncA
protein was PCR amplified in an analogous manner using the
following primer set: IncAPsi4: 59-GCGAATTCACTCCCTCT-
CAAGTGGCACGC-39 (aa 121-383) and IncAPsi2. PCR fragments
were digested with EcoRI-BamHI and transferred into the GAL4 BD
destination vector pGBKT7 (CLONTECH). The C-terminal
deletion fragment of G3BP1 was PCR amplified using the following
primer set: G3BP1d: 59-GCGAATTCGATGATTCTGAGCCTG-
TTCAG-39 and G3BP1b: 59-GCCGTCGACTCACTGCCGT-
GGCGCAAGCC-39and DsRed-G3BP1 vector (kindly provided by
Zhi-Min Yuan, Harvard School of Public Health, Boston, USA) as a
template. PCR fragment was digested with EcoRI-SalI and
transferred into the GAL4 AD destination vector pGADT7
(CLONTECH). S. cerevisiae Y190 (CLONTECH) expressing
pGBKT7-IncA (aa 121-383) was mated for 6 hours with S. cerevisiae
Y187 expressing the HeLa cDNA MATCHMAKER 3 library in the
activation domain (AD) vector pGADT7-Rec (CLONTECH).
Interacting clones were first selected by growth on vector-selective
medium also lacking histidine but containing 5 mM 3-amino-1,2,4-
triazole (3-AT). Emerging colonies were checked for activity of the
second reporter gene lacZ by performing the colony-lift filter assay
using X-Gal (5-Bromo-4-chloro-3-indolyl-a-D-galactopyranoside) as
a substrate. HeLa cDNA-expressing plasmids were recovered from
these strains, propagated in E. coli and sequenced to identify coding
sequences. For quantitative two-hybrid assays S. cerevisiae Y190 was
transformed with corresponding pGBKT7- and pGADT7-constructs
and b-galactosidase liquid culture assays, using o-nitrophenyl b-D-
galactopyranoside (ONPG) as substrate were performed according to
the manufacturer’s instructions (CLONTECH) [41]. The b-
galactosidase values represent the mean numbers and standard
deviations of three independent experiments.
Mutagenesis screen procedure
Construction of a mutated cytoplasmic domain of Cp. psittaci
IncA disabled to interact with G3BP1 was performed in S. cerevisiae
using error-prone PCR as already described [42]. Briefly, codon
adapted cytoplasmic domain of IncA (aa 121-383) from Cp. psittaci
was amplified by PCR analogous to the mammalian construct (see
above) and cloned as a NdeI-EcoRI-fragment into pGBKT7 in
frame with the enhanced green flourescence protein (EGFP) from
pEGFP-C1 vector (CLONTECH) resulting in a GAL4 DB-IncA-
EGFP fusion protein. The EGFP protein allowed to exclude frame
shift mutations in the mutated IncA domain constructs. PCR
primers (T7SEQ: 59-GTAATACGACTCACTATAGGGCGA-39
and GFPrev: 59-GCTGAACTTGTGGCCGTTTAC-39) flanking
the IncA domain were used to amplify this region using error-
prone PCR conditions as described [42] but utilizing SAWADY
Taq-DNA-Polymerase (PEQLAB). The liniarized GAL4 DB-
EGFP plasmid and the randomized PCR fragment were then co-
transformed into yeast strain Y190 expressing the GAL4 AD-
G3BP1 library plasmid (Fig. 1B). The high efficiency of
homologous recombination in yeast, between the linearized
plasmid and the PCR fragment, enabled expression of randomized
cytoplasmic IncA domain chimeric proteins within yeast cells,
permitting detection of those not binding to G3BP1 but still
expressing EGFP via flourescence microscopy and colony-lift filter
assay as described above.
GST pull-down
To produce GST-tagged IncA protein fragments, full-length
and C-terminal cytoplasmic fragments from IncA of Cp. psittaci
DC15 were transferred from corresponding pGBKT7-constructs
(see Yeast two-hybrid assay section) into expression vector pGEX-
4T-1 (GE Healthcare) encoding GST. To obtain GST-tagged full-
length G3BP1 protein (aa 1-466) the corresponding DNA
fragment was amplified by PCR using the following primers:
forward-59-GCGAATTCATGGTGATGGAGAAGCCTTAGT-
39, reverse-59-GCCGTCGACTCACTGCCGTGGCGCAAGCC
and DsRED-G3BP1 vector as template. EcoRI-SalI-digested PCR
fragment was transferred into pGEX-4T-1. Plasmids containing
sequences encoding GST, Cp. psittaci DC15 GST-IncA (aa 1-383),
GST-IncA (aa 120-383) and GST-G3BP1(aa 1-466) were
transformed into E. coli strain BL21-CodonPlus-RIL (Stratagene).
13 ml portions of overnight cultures were filled up to 20 ml with
LB medium containing 100 mg of ampicillin/ml and fusion
derivates were induced with 1 mM isopropyl b-D-thiogalactoside
(IPTG) for induction of protein expression. After 1,5 h incubation
cells were collected by centrifugation, resuspended in 1 ml PBS
containing 1 mM PMSF and 10 mM DTT, and then sonicated.
After sonification 1% Triton X-100 was added and samples were
incubated for 30 min at 4uC. Then the lysates were cleared by
centrifugation and the supernatants were subjected to Glutathione
Sepharose affinity chromatography for purification of the GST
fusion proteins as described by the manufacturer (GE Healthcare).
[
35S]-methionine-labeled G3BP1 full-length and IncA cytoplasmic
domain proteins were synthesized in vitro by coupled T7 RNA
polymerase-mediated transcription and translation (IVT) in a
reticulocyte lysate system as described by the manufacturer
(Promega). Glutathione Sepharose beads (50 ml) liganded by either
GST-tagged protein fragments or GST alone were washed with
HB-buffer (20 mM HEPES, 100 mM KCl, 5 mM MgCl2, 0,5%
Igepal-CA630, 0.5 mM dithiothreitol, pH 7.4) and then resus-
pended in 100 ml HB-buffer containing 0.5% Igepal CA630 and
10 ml[
35S]-methionine-labeled protein. After incubation at 4uCb y
constantly rotating for 2 hours, the beads were washed with HB-
buffer extensively. Proteins were eluted from the beads using SDS
sample buffer. After separation by 10% SDS-PAGE, G3BP1 and
IncA cytoplasmic domain were revealed by exposure on KODAK
X-OMAT AR film (Kodak). Analogous GST pull-down experi-
ments were performed with Hep-2 cell lysates instead of [
35S]-
methionine-labeled G3BP1. The associated proteins were pelleted
by centrifugation, washed and analyzed for full-length G3BP1 by
Western blot analysis as described in the co-immunoprecipitation
and Immunoblotting sections.
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